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INTRODUCTION 
The genius of the human mind and the 
resourcefulness of the human hand have 
endowed future generations with an infamous 
legacy—their environment, for which man 
is now more responsible than God. 
Although the United States has achieved technological supremacy 
during the past several decades, it is evident that changes and advance­
ments in technology only serve to hasten the appearance of new issues 
and paradoxes. Certainly one of the major problems evolving from indus­
trialization and mechanization is that of inordinate quantities of poten­
tially toxic materials being inappropriately utilized and indiscriminately 
disseminated into our natural environment. When one thinks in terms of 
drinking, eating, and/or inspiring a portion of this humanly adulterated 
product each day, there is no need to belabor the potential hazard which 
has been created and will continue to be created for man and other animals. 
It appears that scientists along with the other citizenry of our country 
must take immediate action for controlling and preventing environment-
induced diseases. 
Metallic elements are environmental contaminants which merit recog­
nition as culprits. Goldwater and Clarkson (1972) have discussed numerous 
physical adversities including death as a result of chronic or acute 
mercury poisoning. Cadmium may also elicit toxic effects such as nausea 
and vomiting, respiratory insufficiencies, and altered urine biochemistry 
(Fassett, 1972). Smith (1972) has reported that cadmium, nickel, vanadium. 
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arsenic, and manganese may be potential environmental assaultants if 
their use and dissemination is not properly controlled. 
Lead may be described as a useful, desirable, and necessary heavy 
metal which is found in great abundance throughout the world; however, 
this natural substance holds a significant claim to notoriety. Excessive 
quantities of lead produce clinical disease affecting primarily the nerv­
ous system, the hematopoietic system, and the kidneys. Lead poisoning, 
spoken of in the classical sense, has been present on this earth for 
centuries. A vast array of scientific documentation already exists re­
garding incidence, toxic manifestations, diagnosis, and treatment of 
symptomic lead poisoning in man and animals, Zook ^ (1969) and 
Buck (1970) described it as one of the most significant inorganic poi­
sonings in domestic animals. Plumbism in children is generally associated 
with lower socio-economic groups who l ive in dilapidated housing where 
lead-contaminated paint or putty is readily accessible for nibbling 
(Chisolm and Harrison, 1956, Griggs et 1964, Chisolm and Kaplan, 
1968, and Chisolm, 1971). Although pica (habit of eating nonfood sub­
stances) and lead fumes are the normal cause for symptomatic lead poi­
soning in children, adult plumbism is often a result of poor hygienic 
practices in lead-oriented industries (Haley, 1971). Chisolm (1971) 
reported that imbibers of lead-contaminated whiskey and individuals who 
who eat or drink from improperly lead-glazed vessels may also be poten­
tial victims of lead toxicity. 
There are several recent books and review articles that provide 
detailed information relative to environmental lead,including its 
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distribution, input and disposition in man and animals, toxicology and 
pharmacology, biologic or health effects, and nonbiologic effects 
(Tapper and Pfitzer, 1970, DeBruin, 1971, Committee on Biologic Effects 
of Atmospheric Pollutants, 1972, Goyer and Chisolm, 1972, and Hicks, 
1972). Figure 1 is a schematic flow-chart as presented by Goyer and 
Chisolm (1972) which summarizes sources of lead in the environment and 
the consequent effects on our population. 
Aside from symptomatic or acute lead poisoning which is the result 
of a large accumulation of lead over a relatively short period of time, 
there is yet another concern relative to health and the presence of 
lead in our environment. It is essential that we learn whether or not 
current levels of lead absorption are resulting in subtle, subclinical, 
nonspecific effects on the health of our living population. Indisputably 
there has been increased usage and dissemination of this heavy metal 
during recent years, especially in the form of airborne emissions from 
autos and industry; therefore, the margin of safety existing between 
the normal daily intake of lead and that level of consumption which 
actually precipitates overt, recognizable symptoms must be determined. 
Although Goyer and Chisolm (1972) recently stated that the majority 
of the population has not sustained physical or mental debilitation from 
current levels of lead absorption, a preceding report by Tepper 
and Pfitzer (1970) expressed the consensus of several authorities pres­
ently studying the effects of lead. They concurred that at some point 
short of lead toxicity it is quite possible the body's absorption of 
Figure 1, Ecodiagram of lead in the environment and effects on man 
(taken from Goyer and Chisolm, 1972), 
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lead reaches a level sufficient to create significant alterations in 
normal physiologic function. In order to determine the existence and 
subsequent significance of these subclinical or subtle perturbations, 
it is necessary that techniques be developed which are more sensitive 
and specific than the conventional devices now being employed for de­
tection of lead effects. When this has been accomplished, we will be 
better equipped to determine the magnitude of threat which industrial 
utilization of lead poses to the health and welfare of that portion of 
our human and animal population which is exposed to appreciable quanti­
ties of lead each day. 
All normal mammals are equipped with a highly-developed immune 
system which is essential for their well-being throughout l ife. Immu­
nologic phenomena have been classically placed into two definite cate­
gories (1) nonspecific or innate immunologic responses and (2) specific 
acquired immunologic responses. According to Bellanti (1971), the three 
primary functions performed by these immunologic processes are "defense"-
protection of the individual against invasion by microrganisms, "homeo­
stasis"- removal of effete and damaged cells, and "surveillance"- recog­
nition and destruction of mutant cells. Although complex and variable 
owing to the many interacting natural and acquired immunologic factors 
(Figure 2), this physiologic system is tremendously efficient and well-
organized. If subtoxic levels of lead impair, destroy, alter, or diminish 
one or more of the major defensive components, the implications could be 
highly significant with regard to our human and animal populations. 
First of all, if such a phenomenon does exist, it could yield individuals 
7 
I. Natural immunity (nonspecific) 
A. Physical barriers (skin and mucous membranes) 
B. Cellular barriers (phagocytic cells, reticuloendothelial 
system and inflammatory response) 
C. Humoral barriers (complement, properdin, lysozyme, skin 
secretions,.natural antibodies, etc.) 
II. Acquired immunity (specific) 
A. Antibody production 
B. Cell-mediated response (delayed hypersensitivity) 
Figure 2. Classification of immunity. 
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with enhanced susceptibility to certain bacterial and viral organisms 
thereby dramatically increasing the severity of infection and disease. 
Subsequently, unwarrented stress may be imparted to vital organs of the 
body due to repeated and progressively debilitating infections. De­
pending upon the focal point of the infectious agent, it is also quite 
possible that specific organs would sustain permanent damage. 
Although the literature is not replete with information concerning 
the effects of lead and other pollutants on the immune system, there has 
been definite indication that subclinical levels of lead influence or 
interfere with one or more specific defense mechanisms. Through the 
expansion of immunologic research into diverse clinical and experimental 
areas, resistance and immunologic activities have been well-defined 
during the past several years; therefore, the immune response system 
could provide an extraordinarily sensitive approach to studying sub­
clinical effects of lead. It is imperative at this point in time that 
definitive, sensitive assays be developed for detection of minimal 
alterations in normal physiological mechanisms. 
This project was initiated in an effort to determine the effects 
of various levels of lead on the humoral immunologic system of young 
sheep. Two areas of experimentation were followed in this research 
endeavor. The first was designed to evaluate the development and alter­
ations in serum proteins, especially in immunoglobulins, as a response 
to dietary lead. The second area of investigation involved studying 
specific antibody synthesis and activity in lead-treated animals. 
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HISTORICAL 
Williams ^ a^. (1954) were the first to indicate that lead may be 
an immunosuppressive agent. This relationship was expressed by patho­
logical evidence obtained from an autopsy of a 23-month-old child with 
an extensive history of paint nibbling. Although the youngster's blood 
lead level had reached 0.348 mg per 100 ml at the time of death, the 
pathological abnormalities of the central nervous system were more 
indicative of a bacterial septicemia than of lead toxicity. After 
demonstrating that lead precipitates gamma globulins in vitro, the 
investigators concluded that the child's death may have been the result 
of lead-imposed inactivation of antibodies, thus allowing unrestricted 
growth of pathogenic agents and elaboration of toxic products. 
Evidence in the literature strongly suggests that various environ­
mental pollutants alter an animal's resistance to infection. Research 
by Rylander (1969 and 1970) indicated that sulfur dioxide, carbon dust, 
and cigarette smoke may interfere with an animal's defense against sub­
sequent infectious agents. 
Recent documentations have revealed that lead acetate administered 
simultaneously with endotoxins from various gram negative bacteria poten­
tiates the toxic effect of the endotoxins In certain laboratory animals. 
Selye aj.. (1966) discussed this effect in rats, a species which is 
normally resistant to infection enhancement by bacterial endotoxins. 
They observed a 100,000-fold increase in endotoxin sensitivity of the 
rats which were exposed to a nontoxic dosage of lead acetate concurrently 
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with the injection of endotoxin. The researchers speculated that the 
lead acetate acted as a blocking agent for the reticuloendothelial 
system, which plays an integral role in protecting the body against 
endotoxin invasion. Truscott (1970) studied this phenomenon in young 
chicks, with similar results. The toxicity of Escherichia coli endo­
toxin was increased 1,000 times when given simultaneously with non­
toxic levels of lead acetate. 
Another il lustration of potential immunologic effects of chemical 
pollutants at sublethal concentrations was presented by Friend and 
Tanner (1970). They found young mallard ducks which had experienced 
previous exposure to nontoxic levels of an organo-chlorine substance 
suffered higher mortality upon challenge with duck hepatitis virus than 
ducklings which had not encountered the hydrocarbon pollutant. This 
report suggested that polychlorinated biphenyls may reduce an animal's 
ability to resist some pathogenic agents. 
After studying the effects of subclinical levels of lead nitrate 
on resistance of mice to Salmonella typhimurium, Hemphill et (1971) 
concluded that lead-treated animals were far less tolerant to bacterial 
challenge than the controls which received no lead. The investigators 
first determined how much lead a mouse can tolerate without manifesting 
clinical symptoms. Once this had been established, the effect of lead 
levels on resistance to infection was tested as follows; 75 mice were 
divided into three equal-sized groups including a control group and two 
exposed groups which received 100 (ig and 250 [xg of soluble lead nitrate, 
respectively. These amounts were injected via the intraperitoneal 
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route on a daily basis for four weeks. Following the period of lead 
exposure, five dilutions (10 10 , 10 10 , and 10 
of a selected strain of Salmonella typhimurium, previously shown to have 
an LDgg of 10 , were prepared for challenging the mice. Each bacterial 
dilution was injected into five mice from each of the three groups. There 
was 100% mortality in the high lead group three days post challenge. The 
mice which received 100 (j,g of lead nitrate per day showed 50% mortality 
within seven days after challenge. Ten days subsequent to challenge 
only 13% of the control group had succumbed to bacterial infection, it 
was concluded that continuous exposure of mice to subclinical levels of 
lead significantly increased their susceptibility to the particular strain 
of Salmonel1 a typhimurium used for chalIenge. 
The aforementioned studies are highly suggestive that various forms 
of lead (and possibly other chemical pollutants) administered at levels 
below the dosage causing clinical toxicity may alter or reduce the effi­
ciency of immune responses. It is yet to be ascertained exactly what 
defense mechanism or mechanisms are affected by lead and how lead acts 
to encroach upon their efficacy. 
There has been scanty Indication in the literature that lead may 
interfere with natural or innate factors of the defense system. 
Kiryachko (1957) and Goreczky et £]_. (1957) have reported lowered com­
plement titers in rabbits suffering from acute or chronic lead poisoning. 
In vitro inhibition of the hemolytic action of guinea pig complement 
has been shown to occur in the presence of lead chloride (Miyazaki, 
1959). Hemphill (1973) demonstrated a complete absence or marked re­
duction of properdin activity in lead-treated mice. Workers in a lead 
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smelting plant, where high level exposure to lead occurred on a daily 
basis, manifested derangement in phagocytic and bactericidal activity 
of their blood, deficiency in salivary Iysozyme levels, and changes in 
anti-microbial activity of the buccal mucosa (Rakhimova, 1968). Contrary 
to this trend of inhibition, Goreczky et (1957) noted a rise in the 
opsonic activity of rabbit serum after exposure to lead acetate. Altera­
tions in ciliary function and efficiency of alveolar phagocytes in the 
lung after exposure to carbon dust and toxic gases have also been dis­
cussed (Green, 1970). 
Although results have been somewhat inconsistent, several reports 
can be found in the literature relative to serum protein levels in indi­
viduals exposed to abnormally high levels of lead. Kapetanovic et al. 
(i960) analyzed serum protein fractions from 36 persons with chronic 
lead poisoning. The major alterations appeared in the albumin fraction 
which decreased by an average of 20% and the gamma-globulin component 
which showed an average dimunution of 50%. Contradictory to these 
findings, Soliman et aj[. (1970), In their study of 112 Egyptian lead 
workers, found 17% exhibited a significant reduction in alphaj-globulin 
and alpha2-globulin levels. The albumin, beta-globulin, and gamma­
globulin levels were virtually unchanged. Observations made by Cervetti 
and Casucci (I96O) on individuals suffering from severe lead poisoning 
yielded results somewhat divergent from those previously discussed. 
Their study revealed a decrease of total protein and albumin levels in 
several individuals while an enhancement beyond normal levels was shown 
in the alpha, beta, and gamma serum constituents. Hayashi et al. (1959) 
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induced lead poisoning in rabbits by various routes of exposure. 
El ectrophophoretic analysis indicated elevated gamma-globulin in animals 
poisoned via the injectant or inhalant routes. The other major alter­
ation occurred in the albumin fraction which decreased significantly 
after inhalation of lead compounds. 
Minimal documentation is available concerning the effect of lead 
and other environmental irritants on specific immunity or the synthesis 
and mobilization of antibodies against antigenic stimuli. In 1955 Belli 
e_t published a series of papers which evaluated immunologic processes 
in rabbits exposed to high levels of tetraethyl lead. They found no in­
crease in antibody globulins following injection of poisoned rabbits 
with Streptococcus antigen. Another group of rabbits was subjected to 
Salmonella typhi in order to determine specific agglutinin titers pro­
duced against that organism. Again, the antibody response was definitely 
impaired. To further verify these studies, Giuliani and Belli (1956a 
and 1956b) demonstrated reduced agglutinin titers in lead-treated rabbits 
challenged with Brucella melitensis and typhoid antigen. Hemphill (1973) 
recently noted a significant reduction of antibody titers against 
Salmonella typhimurium in lead-treated mice, as compared to control mice. 
Control and carbon-dust exposed mice have been compared in their 
ability to respond to antigens administered via the intraperitoneal, 
intravenous, and inhalation routes (Zarkower and Morges, 1972). Although 
carbon manifested an overall immunosuppressive effect, the diminution 
in antibody-forming cells and serum agglutinin titers was most pronounced 
when the antigen was given as an aerosol by inhalation. After four days 
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pre-exposure to carbon dust, there occurred an increase in antibody-
forming ceils in the mediastinal lymph nodes. However, this was 
apparently a transient effect because it disappeared when carbon pre­
exposure was continued for 15 days. 
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EXPERIMENTAL PROCEDURES 
Lambs 
Twenty-five normal, healthy, Columbia-Rambouilet crossbred lambs 
obtained from inresidence breeding stock maintained at the Behavioral 
Toxicology Laboratory, Iowa State University were used in this study. 
All of the lambs were born between June 6, 1972 and August 22, 1972. 
Their individual birthweights were in the range of 4 to 8 kg. At 
birth, each animal was assigned a number in sequential fashion (lamb 
1-#51, lamb 2-#6l, lamb 3-#71, lamb 4-*8I, lamb 5-#91> lamb 6-#52, etc.) 
and was then placed by that number into one of five groups as follows: 
group 1, lambs #51-#55; group 2, lambs #61-#65; group 3, lambs #71-#75; 
group 4, lambs #81-#85; group S, lambs #91-#95. Numbered ear tags and 
back markings were used to identify each of the 25 animals. After the 
lambs were weaned at approximately 6 weeks of age, they were maintained 
on a commercial lamb supplement^ and received water ad Iibiturn. 
Lead Compounds 
Lead acetate crystals (reagent grade) were obtained from a com-
2 
mercial source. Two basic lead stock solutions were utilized for oral 
exposure of Iambs. These solutions were prepared by dissolving lead 
acetate in distilled water at concentrations of 10 mg/ml and 20 mg/ml, 
respectively. Test Iambs received a prescribed volume of one of these 
*B-P Lamb Starter Pellets, Protein Blenders, Inc., Iowa City, Iowa. 
2 J. T. Baker Chemical Co., Phillisburg, New Jersey. 
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standard lead solutions each day, as dictated by their weights and the 
exposure group to which they belonged. All lambs were force-fed using 
plastic tubing and a syringe. 
Lead Exposure 
Each lamb, except for those in the control group, received a daily 
(5 days/week) oral dosage of lead in the form of solubilized lead ace­
tate according to the following paradigm: group 1 (control group), no 
lead; group 2, 2 mg lead/kg body weight; group 3, 4 mg lead/kg body 
weight; group 4, 8 mg lead/kg body weight; and group 5, 16 mg lead/kg 
body weight. Lead exposure for each lamb began at 5 days of age and 
continued for approximately 12 weeks (60 dosage days). The Iambs were 
weighed each Monday throughout the period, In order to determine the 
amount of lead which they were to receive during the forthcoming week. 
Lead exposure was terminated after 12 weeks because 3 lambs in group 5 
(l6 mg/kg) succumbed to irreversible lead toxicosis, and our objective 
was to standardize the period of lead exposure across all groups. 
Blood Collection 
Venous blood samples were collected In heparinized lead-free 
Vacutainers' from the lead-treated and control lambs. The initial 
heparinized blood sample (10 ml) was obtained from each lamb at 5 days 
of age. Subsequent samples were collected at intervals of 2, 4, 8, 12, 
16, 20, 24, and 28 weeks. After each collection, these blood samples 
] 
Becton-Dickinson and Company, Rutherford, New Jersey. 
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were analyzed for lead by the method of atomic absorption spectro­
photometry (Hessel, 1968). 
Serum Collection and Storage 
Blood samples (10 ml) collected in anticoagulant-free Vacutainers '  
were allowed to clot at room temperature for approximately 1 hr. The 
clotted blood samples were refrigerated at 4 C overnight and then were 
centrifuged at 850 x g for 15 min to separate sera. Each of the serum 
samples was divided into two equal portions, one of which was stored 
under refrigeration at 4 C with merthiolate added to a final concentra­
tion of 0.0001 %, and the other portion was frozen and stored at -20 C. 
After obtaining the first serum sample from each animal at 5 days of 
age, serum collection continued on a weekly basis for a period of 6 
months (28 weeks). 
Serum Protein Evaluations 
Total protein determinations 
2 Total serum protein was measured with a refractometer. This was 
accomplished by holding the instrument in a horizontal plane and applying 
a drop of serum sample (0.05 ml) directly onto the glass window. By ex­
posing the unit to an illuminating source, the value on the scale as 
seen through the eyepiece could be read. This reading represented the 
total quantity of serum protein in g/100 ml. 
Becton-Dickenson and Company, Rutherford, New Jersey. 
2 T. S. Meter, American Optical, Co., Buffalo, New York. 
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Cellulose acetate electropheresis 
Serum proteins were separated in a microzone chamber' on cellulose 
2 3 
acetate membranes using high resolution Tris-barbital buffer , pH 8.8 
and ionic strength of 0.05. Eight serum samples each of approximately 
0.25-|j,l volume were applied to each membrane. As the microzone cell 
accommodated 3 membranes, it was possible to electropheretically sepa­
rate 24 serum samples simultaneously. Twenty-five minutes treatment at 
250 V separated the serum proteins. Following electrophoretic migration, 
4 the proteins were stained with Ponceau S. 
A photoelectric densitometer^ was utilized to scan the membranes 
and to print out an integrated density curve based on the amount of 
light absorbed by the stained protein bands. Optical density of the 
separated protein fractions was evaluated at 6OO nm. For quantitative 
evaluation of the completed electrophoretic patterns, individual peaks 
were separated by drawing vertical lines through their lowest points. 
As the number of integrative pulse strokes between vertical lines is 
representative of the area under the curve, division of each component 
area count by total count yielded the relative percentage of each major 
'srinkman Sartorius, Brinkman Instruments, Westbury, New York. 
2 Beckman Instruments, Fullerton, California. 
^Gelman Instrument Company, Ann Arbor, Michigan. 
4 Buchler Instruments, Ft. Lee, New Jersey. 
^Model RllO, Beckman Instruments, Fullerton, California. 
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serum protein fraction contained in the sample. Relative concentra­
tions were readily converted to absolute weights by multiplying total 
protein content by percentage composition. 
Details of this procedure may be found in the Appendix. 
Immunoelectrophoresi s 
A modification of Scheidegger's (1955) microslide immuno­
electrophoresi s technique was utilized in this study for separating and 
differentiating serum protein components, including the immunoglobulin 
subgroups. Immunoelectrophoresis was carried out in 1% Noble Agar' 
and high resolution Tris-barbital buffer at pH 8.8 and 0.05 M ionic 
strength. After deposition of serum into the wells, the samples were 
electrophoresed in a chamber for 120 min at 4-5 ma (75 v) per frame. 
The troughs were then fil led with approximately 0.15 ml of rabbit anti-
sheep serum^, and the slides were allowed to incubate in a humidified 
atmosphere for 16-20 hr at room temperature. Following complete develop­
ment of the precipitin lines, the immunoelectrophoretic patterns were 
photographed using a Nikon Photomic FTj^ (automated reflex) camera.^ 
Details of this procedure may be found in the Appendix. 
'oifco Laboratories, Inc., Detroit I, Michigan. 
2 Gelman Deluxe Electrophoresis Chember, Gelman Instrument Company, 
Ann Arbor, Michigan 
^Schwarz/Mann, Division of Becton-Dickinson and Company, 
Orangeburg, New York. 
4 Nippon Kogaku K. K., Japan. 
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Development of Specific Immune Response 
Antigen 
A heat-killed bacterin of Serrâtia marcescens was used in this 
study. The vaccine was prepared by seeding the surface of layered 
nutrient agar contained in a Kolle flask with 10 ml of a 19-hr Serrâtia 
marcescens (obtained from culture collection. Department of Bacteriology, 
Iowa State University, Ames, Iowa) broth culture. After incubation at 
25 C for 24 hr, the cells were collected into a sterile centrifuge tube 
by washing the agar several times with sterile physiological saline. 
The bacterial suspension was boiled for 2 hr, then it was collected in 
a RC2-B refrigerated centrifuge' for 1/2 hr at 1400 x g using the SS-34 
angle head rotor. This step was followed by resuspension in sterile 
saline to a concentration of 10% (v/v). Sterility was checked by appro­
priate bacteriologic tests; the suspension was then placed in a sterile 
vaccine bottle, and it was stored in the refrigerator at 4 C. For 
the purpose of immunizing lambs, it was diluted with saline to a 
density of Tube 4 on the McFarland nephelometer scale (approximately 
10^ bacteria/ml) (Campbell et £l^., 1970). 
Immunization schedule 
Upon reaching 6 weeks of age, each of the 25 lambs was inoculated 
intravenously (jugular vein) with 6 injections of heat-killed Serrâtia 
marcescens, according to the paradigm presented in Table I. 
'ivan Sorvall, Inc., Norwalk, Connecticut. 
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Table 1. Injection schedule for 6 week old lambs 
Day Ml No. of eel 1 s Route 
1 0.5 1.5 X lo9 1ntravenous 
3 0.5 1.5 X 10^ Intravenous 
5 0.5 1.5 X 10^ 1ntravenous 
7 1.0 3.0 X 10^ 1ntravenous 
14 1.0 3.0 X 10^ 1ntravenous 
21 1.0 3.0 X 10* 1ntravenous 
Approximately 60 days after the final injection of the initial 
series, each animal received a secondary injection of Serratia marcescens, 
q (I ml, 3.0 X 10 cells) intravenously or subcutaneously. This later 
exposure was given for the purpose of evaluating the secondary or 
anamnestic response. 
Antibody titration 
Modifications of combined passive hemagglutination techniques of 
Neter et al. (1956) and Field et al. (1970) were used to determine anti­
body titers. The Microliter System' was employed in this study. 
2 Serratia marcescens endotoxin prepared at a concentration of 
10 mg/ml was used to sensitize sheep erythrocytes at a ratio of 1 part 
'cooke Engineering Company, Alexandria, Virginia. 
2 Difco Laboratories, Inc., Detroit 1, Michigan. 
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red blood cells to 4 parts endotoxin. This red eel 1-1ipopolysaccharide 
mixture was incubated for 1/2 hr at 37 C. The treated cells were then 
washed 3 times by serial centrifugation, using 0.85% NaCl as suspending 
medium. After washing was completed, the modified cells were resus-
pended to a concentration of 2.5% (v/v) with PO^-buffered saline, and 
were again diluted to a concentration of 0.5% for use in the passive 
hemagglutination test. 
The procedure for the hemagglutination test was as follows: 
employing a Microti ter pipette, 0.025 ml of 1% normal rabbit serum 
was placed in each well of a Microti ter U plate. After adding 0.025 ml 
of test serum (diluted 1:5) to the first well, two-fold serial dilu­
tions were made. Next, 0.025 ml of the endotoxin-sensitized sheep red 
blood cells was added to each well. Plates were incubated for 1 hr at 
37 C, and then were stored overnight in the refrigerator. Serum anti­
body titers were expressed as the reciprocal of the highest dilution 
of serum that produced complete agglutination of the 1ipopolysaccharide-
coated sheep red blood cells. 
Treatment of the serum samples with 2-mercaptoethanol (2-ME), a 
sulfhydryl reducing agent which inactivates 19S gamma globulin, served 
as a crude indication of 7S and igS antibody. Duplicate samples of 
sera were incubated for 1 hr at 37 C with an equal volume of 0.2 M 
2-ME before dilution. The sera were than treated as previously described 
(Field et al^., 1970). 
Details of this procedure may be found in the Appendix. 
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RESULTS 
Blood Lead Determinations of 
Control and Lead-Treated Lambs 
The mean blood lead level for the control lambs (group 1) was 
11. 7  p g / l O O  m l ;  g r o u p s  2 ,  3 ,  4  a n d  5  w h i c h  i n d i v i d u a l l y  r e c e i v e d  2 ,  k ,  
8 and 16 mg lead/kg body weight displayed mean blood lead levels of 
37.2, 56.8, 67.6 and 99.8 (ig/lOO ml, respectively. Group means for 
blood lead residues obtained at specific intervals are displayed in 
Table 2. 
After subjecting these data to an analysis of variance, the LSD 
values (Steel and Torrie, I960) were utilized to determine whether the 
overall mean blood lead levels of the five groups were significantly 
different from one another. A summarization of the statistical com­
parisons between the experimental groups of lambs appears in Table 3. 
A statistically significant difference at the 1% level existed between 
all groups, except for groups 3 and 4. Although analysis of overall 
mean values reflected at least three distinct levels of lead feeding, 
group means for blood lead were not consistently distinct throughout 
the experimental period, especially after termination of lead exposure. 
Serum Protein Analysis of 
Control and Lead-Treated Lambs 
Total serum protein values, as measured with a refractometer, and 
serum protein patterns obtained by electrophoresis on cellulose acetate 
membranes, were employed to derive quantitative data for individual 
lambs at weekly intervals following initiation of lead treatments at 
Table 2. Blood lead levels in control and lead-treated lambs^ 
Age 
(Days) 
Group 1 
Control 
Mean blood 
Group 2 
2 mg/kg 
level (ug/lOO ml) 
Group 3 Group 4 
4 mg/kg 8 mg/kg 
Group 5 
16 mg/kg 
5 11.4 12.0 15.6 14.2 15.2 
14 10.8 47.6 66.8 66.6 108.4 
28 12.6 64,6 106.8 112.5 163.8 
56 16.2 55.0^ 77.0 125.0 160.0 
84*^ 14.6 39.5^ 57.0^ 85.6 99.3^ 
112 6.0 18.0^ 36.5^ 45.6 48.0^ 
140® 
- - - -
168 8.6 20.5^ 28.0^ 32.6 31.5^ 
^Groups 1, 2, 3j 4 and 5 ingested 0, 2, k, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred 
''Lead exposure was terminated prior to 84th day. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred 
®No data due to laboratory error. 
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Table 3. Statistical comparisons of blood lead levels in control and 
lead-exposed Iambs 
Group Group 
compari sons 
Probabi1i ty 
values 
1 
control 
2 mg lead/kg body weight 
4 mg lead/kg body weight 
8 mg lead/kg body weight 
16 mg lead/kg body weight 
1 vs 2 
1 vs 3 
1 vs 4 
1 vs 5 
2 vs 3 
2 vs 4 
2 vs 5 
3 vs 4 
3 vs 5 
4 vs 5 
(P<0.01) 
(P<0.01) 
(P<0.01) 
(P<0.01) 
(P<0.01) 
(P<0.01) 
(P<0.01) 
No 
significant 
di fference 
(P<0.01) 
(P<0.01) 
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5 days of age. All of the electrophoretic patterns showed excellent 
resolution into five component peaks composed of the following proteins: 
albumin, alpha^ (a^)-globulin, alphag (Og)-globulin, beta (p)-globulin, 
and gamma (y)-globulin. 
it was considered highly redundant to engage in the cumbersome 
task of presenting, evaluating, and analyzing weekly data from each of 
the test animals; therefore, nine sampling dates were selected to pro­
vide a representative set of data for determining the existence of 
alterations or significant trends which might be occurring in the serum 
protein profiles of the lambs. All individual lamb data, and other 
data compilations obtained throughout this experimental undertaking are 
on file at the Veterinary Diagnostic Laboratory, Iowa State University, 
Ames, Iowa. 
Tables if, 5, 6, 7> 8 and 9 summarize mean values of the calculated 
serum protein concentrations in grams/100 ml for each group of lambs at 
5, l4, 28, 42, 56, 84, 112, 140 and I68 days of age, respectively. 
Range values, along with overall group-and time-means, also appear in 
the tables. 
All serum-protein data were subjected to an analysis of variance 
to test for significant effects of lead exposure on each parameter 
measured. The analysis of mean total protein levels (Table 4) Indi­
cated that no significant group differences were present. Although one 
of the lead-treated groups manifested a sharp decrement in total protein 
at 84 days, there Is no indication that this change resulted directly 
Table 4. Total protein values in control and lead-treated lambs® 
Total protein (grams/100 ml serum)^ 
Age 
(Days) Group I Control 
Group 2 
2 mg/kg 
Group 3 
4 mg/kg 
Group 4 
8 mg/kg 
Group 5 
16 mg/kg 
Mean 
5 5.55 
(5.30-5.90) 
5.06 
(4.10-6.40) 
5.90 
(5.30-6.80) 
5.52 
(4.50-6.60) 
5.62 
(5.00-6.30) 
5.53 
14 5.44 
(5.30-6.00) 
5.28 
(4.70-5.90) 
5.24 
(4.00-6.30) 
5.76 
(4.80-6.70) 
5.54 
(4.50-6.20) 
5.45 
28 5.26 
(4.70-6.60) 
5.33 
(4.95-6.40) 
5.34 
(4.90-5.80) 
5.30 
(4.70-5.70) 
5.50 
(5.20-6.30) 
5.35 
42 5.50 
(4.70-6.60) 
5.43 
(4.70-6.50) 
5.05 
(4.10-5.60) 
5.14 
(4.10-5.80) 
5.24 
(4.80-5.00) 
5.27 
56 5.63 
(5.20-6.70) 
5.19c 
(4.50-5.80) 
6.06 
(4.80-8.80) 
5.82 
(5.50-6.70) 
5.62 
(4.60-7.20) 
5.71 
84 6.50 
(5.60-7.50) 
5.10^ 
(4.60-6.50) 
4.97C 
(4.40-8.40) 
5.70 
(5.10-6.00) 
S . l f  
(4.90-6.30) 
5.64 
112 6.65 
(5.70-7.20) 
6.24C 
(5.75-7.30) 
6.22= 
(5.50-6.55) 
6.17 
(5.40-7.20) 
5.96^ 
(5.40-5.80) 
6.25 
140 6.61 
(6.00-7.50) 
6.63^ 
(5.85-8.35) 
6.29^ 
(5.80-6.85) 
6.63 
(5.40-7.40) 
6.36^ 
(5.60-6.40) 
6.43 
168 6.72 
(6.30-7.30) 
6.34^ 
(5.80-7.40) 
6.30= 
(5.80-6.60) 
6.36 
(5.60-7.30) 
6.41^ 
(5.60-6.30) 
6.41 
Mean 5.98 5.65 5.64 5.79 5.59 
^Groups I, 2, 3, 4 and 5 ingested 0, 2, 4, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
^Mean and range of values observed from each group. 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
28 
from lead encounter. A general trend of increasing total protein 
concentration with increasing age was observed in all groups. 
The analysis of the albumin data (Table 5) indicated a highly 
significant effect (P<.0001) of time, but no difference among the 
groups. All of the lead-treated groups displayed a drop in albumin 
on day 84, while the control group showed an increase at this point. 
The mean values did not differ markedly throughout the experiment; 
however, there was a trend of increasing albumin in all groups. 
A significant difference among groups (P<.046) was detected for 
the Oj-globulin component (Table 6). In order to determine where the 
differences occurred, LSD values were utilized for comparing group means 
(LSD value for comparing any two group means at the 5% level=.0593 and 
at the 1% 1evel=.0889). The two highest lead treatment groups (4 and 5) 
differed significantly from the control group, as well as from group 2 
at the 5% level. Although the validity of comparing overall mean values 
may be questioned when there is substantial variation in normal 5-day 
levels across all groups, in this particular instance, groups 4 and 5 
were consistently higher than the other groups. 
Analysis of variance indicated a significant group effect (P<.046) 
for mean 0^-globulin levels, which are displayed in Table 7. Overall 
group means were then compared using LSD values (LSD value for comparing 
any two group means at the 5% level=.1711 and at the 1% level=.2333); 
groups 3, 4 and 5 were found to be significantly different from the 
control group. The trend exhibited in this parameter may well be given 
Table 5. Albumin values for control and lead exposed lambs® 
Albumin (grams/100 ml serum)^ 
Age 
(Days) 
Group 1 
Control 
Group 2 
2 mg/kg 
Group 3 
4 mg/kg 
Group 4 
8 mg/kg 
Group 5 
16 mg/kg 
Mean 
5 2.05 
(1.86-2.26) 
2.00 
(1.67-2.40) 
2.19 
(1.74-2.71) 
1.92 
(1.57-2.24) 
1.98 
(1.93-2.12) 
2.03 
14 1.99 
(1.64-2.44) 
2.16 
(1.93-2.39) 
1.90 
(1.60-2.53) 
2.19 
(1.78-2.91) 
2.14 
(1.61-2.51) 
2.08 
28 2.17 
(1.90-2.56) 
2.28 
(1.80-2.55) 
2.08 
(1.96-2.16) 
2.19 
(1.75-2.63) 
2.27 
(1.75-2.84) 
2.20 
42 2.41 
(1.96-3.00) 
2.29 
(1.97-2.48) 
2.23 
(1.78-2.42) 
2.24 
(1.46-2.76) 
2.10 
(1.79-2.44) 
2.25 
56 2.29 
(1.80-2.93) 
1.98= 
(1.73-2.26) 
2.33 
(1.77-3.46) 
2.41 
(2.19-2.76) 
2.30 
(1.87-3.57) 
2.28 
84 2.50 
(2.03-3.04) 
1.88= 
(1.60-2.15) 
1.94= 
(1.61-2.06) 
2.13 
(1.89-2.25) 
2.07= 
(1.91-2.30) 
2.12 
112 2.52 
(2,38-2.76) 
2.33= 
(1.98-2.95) 
2.40= 
(1.86-2.82) 
2.42 
(1.71-3.23) 
2.15^ 
(2.04-2.06) 
2.38 
140 2.52 . 
(2.37-2.67) 
2.43= 
(2.14-3.07) 
2.52= 
(1.98-2.79) 
2.40 
(1.91-2.94) 
2.69^ 
(2.34-2.84) 
2.47 
168 2.55 
(1.98-2.88) 
2.37= 
(2.06-2.71) 
2.50= 
(2.03-2.51) 
2.53 
(2.40-2.63) 
2.28^ 
(2.17-2.18) 
2.45 
Mean 2.33 2.20 2.20 2.26 2.16 
^Groups 1, 2, 3, 4 and 5 ingested 0, 2, 4, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
^Mean and range of values observed from each group. 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
Table 6, Alphas-globulin values for control and lead-exposed lambs® 
Alphaj-globulin (grams/100 ml serum)^ 
Age 
(Days) Group 1 Control 
Group 2 
2 mg/kg 
Group 3 
4 mg/kg 
Group 4 
8 mg/kg 
Group 5 
16 mg/kg 
Mean 
5 0.38 
(0.34-0.42) 
0.32 
(0.14-0.47) 
0.46 
(0.41-0.51) 
0.37 
(0.23-0.50) 
0.41 
(0.23-0.55) 
0.39 
14 0.21 
(0.00-0.37) 
0.26 
(0.17-0.43) 
0.23 
(0.00-0.43) 
0.38 
(0.26-0,56) 
0.36 
(0.19-0.44) 
0.29 
28 0.34 
(0.20-0.40) 
0.20 
(0.17-0.23) 
0.29 
(0.20-0.44) 
0.42 
(0.32-0.50) 
0.47 
(0.26-0.76) 
0.34 
42 0.30 
(0.14-0.51) 
0.23 
(0.17-0.27) 
0.27 
(0.18-0.40) 
0.46 
(0.30-0.69) 
0.37 
(0.21-0.56) 
0.33 
56 0.39 
(0.33-0.46) 
0 , 2 f  
(0.20-0.44) 
0.42 
(0.23-0.63) 
0.33 
(0.23-0.39) 
0.35 
(0.20-0.51) 
0.36 
84 0.18 
(0.00-0.36) 
0.36^ 
(0.16-0.50) 
0.31 = 
(0.27-0.35) 
0.31 
(0.18-0.37) 
0.35= 
(0.27-0.45) 
0.30 
112 0.25 
(0.00-0.45) 
0.35= 
(0.25-0.47) 
0.41 = 
(0.35-0.50) 
0.37 
(0.28-0.46) 
0.41^ 
(0.40-0.41) 
0.35 
140 0.44 
(0.28-0.57) 
0.44= 
(0.27-0.80) 
0.47= 
(0.45-0.51) 
0.45 
(0.28-0.59) 
0.33^ 
(0.22-0.42) 
0.44 
168 0.43 
(0.17-0.50) 
0.25= 
(0.16-0.47) 
0.44= 
(0.39-0.54) 
0.39 
(0.00-0.58) 
0.40^ 
(0.32-0.47) 
0.38 
Mean 0.32 0.29 0.36 0.39 0.38 
^Groups 1, 2, 3) 4 and 5 ingested 0, 2 ,  k ,  8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
^Mean and range of values observed from each group. 
''Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
'^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
Table 7. Alphaj-globulin values for control and lead-exposed lambs® 
Alpha2-g1obulin (grams/100 ml serum)^ 
Age Group 1 Group 2 Group 3 Group 4 Group 5 Mean 
(Days) Control 2 mg/kg 4 mg/kg 8 mg/kg 16 mg/kg 
5 1.17 1.08 1.26 1.12 1.02 1.13 
(0.87-1.13) (0.75-1.40) (0.92-2.00) (0.74-1.46) (0.84-1.14) 
14 1.48 1.19 1.26 1.22 1.12 1.26 
(1.07-1.80) (0.96-1.40) (1.07-1.42) (0.86-1.59) (0.92-1.37) 
28 1.18 1.28 1.21 1.09 1.09 1.17 
(1.05-1.34) (1.13-1.57) (0.76-1.88) (0.80-1.51) (0.78-1.31) 
42 1.32 1.32 0.96 0.95 1.07 1.13 
(1.22-1.55) (1.04-1.72) (0.79-1.14) (0.70-1.21) (0.80-1.26) 
56 1.11 I.17G 1.17 1.21 1.05 1.15 
(0.94-1.23) (0.89-1.56) (0.93-1.84) (0.89-1.38) (0.97-1.14) 
84 1.53 O.96C 0.84c 1.15 1.08= 1.13 
(1.22-2.02) (0.87-1.13) (0.72-0.83) (0.95-1.50) (0.82-1.24) 
112 1.45 I.23C O.96C 1.20 0.94^ 1.20 
(1.11-1.81) (0.93-1.60) (0.81-1.14) (0.88-2.09) (0.85-0.97) 
140 1.11 I.26C 0.92= 1.04 0.87^ 1.06 
(0.96-1.25) (0.89-1.63) (0.69-1.25) (0.88-1.25) (0.76-0.91) 
168 1.11 I.23C 0.91 = 0.86 0.97^ 1.02 
(0.99-1.25) (1.12-1.36) (0.85-0.91) (0.57-1.04) (0.92-0,96) 
Mean 1.27 1.22 1.06 1.09 1.04 
^Groups 1, 2, 3^ 4 and 5 ingested 0, 2, 4, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
Mean and range of values observed from each group. 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
32 
consideration as a legitimate effect of lead, even though some dis­
parity did exist in normal mean levels at 5 days of age. 
An analysis of the ^-globulin data (Table 8) indicated a signifi­
cant effect of time (P<.0001), but the changes due to time were not 
linear over the course of the experiment. Although there was no sig­
nificant group effect, the analysis indicated a significant group-by-
time interaction (P<.002), but the measured values for each group of 
animals were so variable from one sampling date to the next that it 
was difficult to attach a meaningful interpretation to these findings. 
Mean 7-globulin levels (Table 9) increased significantly (P<.OI) 
during the course of this experimentation, but no group differences 
were indicated. The general trend of decreasing 7-globulîn concentra­
tions from day 5 to day 42, followed by a constant increase through­
out the remaining weeks, was observed in all groups. 
In an effort to exclude the unpredictable effect which an anti­
genic stimulus might impose upon the distribution of various protein 
components (possibly masking the effect of lead as a single known 
variable), an analysis of variance was performed on those data collected 
on days 5, 14, 28 and 42 (prior to antigenic exposure). Only in the 
case of the O^-globulin fraction was there an indication of a signifi­
cant group (treatment) effect. However, these differences were thought 
to be due to chance and were not considered to be reflective of change 
inouced by lead exposure. 
There was often a marked disparity in normal mean serum protein 
values among groups of lambs at 5 days of age; therefore, the 
Table 8. Beta-globulin values for control and lead-exposed lambs® 
Beta-globulin (grams/100 ml serum)^ 
Age 
(Days) 
Group 1 
Control 
Group 2 
2 mg/kg 
Group 3 
4 mg/kg 
Group 4 
8 mg/kg 
Group 5 
16 mg/kg 
Mean 
5 0.44 
(0.30-0.67) 
0.29 
(0.16-0.39) 
0.58 
(0.31-1.00) 
0.23 
(0.00-0.42) 
0.38 
(0.30-0.53) 
0.39 
14 0.55 
(0.51-0.59) 
0.42 
(0.40-0.45) 
0.49 
(0.42-0.56) 
0.45 
(0.36-0.59) 
0.49 
(0.40-0.59) 
0.48 
28 0.52 
(0.47-0.58) 
0.53 
(0.31-0.68) 
0.54 
(0.48-0.57) 
0.35 
(0.00-0.57) 
0.47 
(0.00-0.57) 
0.48 
42 0.55 
(0.39-0.82) 
0.58 
(0.40-0.78) 
0.53 
(0.44-0.63) 
0.49 
(0.35-0.64) 
0.46 
(0.36-0.54) 
0.52 
56 0.58 
(0.48-0.77) 
0.49c 
(0.47-0.55) 
0.58 
(0.51-0.74) 
0.58 
(0.41-0.73) 
0.49 
(0.40-0.61) 
0.55 
84 0.55 
(0.40-0.66) 
0.36^ 
(0.32-0.50) 
0.41 = 
(0.30-0.58) 
0.44 
(0.34-0.51) 
O.43C 
(0.28-0.56) 
0.44 
112 0.43 
(0.35-0.48) 
0.44c 
(0.44-0.48) 
0.38= 
(0.32-0.43) 
0.48 
(0.38-0.63) 
0.41^ 
(0.35-0.42) 
0.44 
140 0.51 
(0.39-0.58) 
0.59f 
(0.47-0.73) 
0.42^ 
(0.37-0.53) 
0.51 
(0.44-0.62) 
0.34^ 
(0.29-0.33) 
0.49 
168 0.59 
(0.47-0.76) 
0.57^ 
(0.44-0.96) 
O.45C 
(0.37-0.54) 
0.57 
(0.44-0.84) 
0.46^ 
(0.31-0.56) 
0.54 
Mean 0.53 0.48 0.49 0.45 0.44 
^Groups 1, 2, 3, 4 and 5 ingested 0, 2, h, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
^Mean and range of values observed from each group. 
**Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
'^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
Table 9. Gamma-globulin values for control and lead-exposed lambs® 
Age Group 1 Group 2 Group 3 Group 4 Group 5 Mean 
(Days) Control 2 mg/kg 4 mg/kg 8 mg/kg 16 mg/kg 
5 1.50 1.37 1.41 1.88 1.83 1.60 
(1.26-2.14) (0.89-2.25) (0.57-1.97) (1.36-2.61) (1.29-2.06) 
14 1.21 1.24 . 1.37 1.52 1.43 1.35 
(1.02-1.54) (0.75-1.70) (0.56-1.89) (1.40-1,73) (0.96-1.74) 
28 1,06 1.05 1.22 1.25 1.20 1.16 
(0.97-1.11) (0,64-1,45) (0,90-1,55) (0.61-1.80) (1.02-1,56) 
42 0.93 1,02 1.06 1.01 1.24 1.05 
(0.60-1,25) (0.73-1.34) (0.68-1.27 (0,78-1.19) (0.80-1.90) 
56 1,25 1.28^ 1,56 1.29 1.43 1.37 
(0.99-1.42) (0.93-1.70) (1.16-2.37) (0.85-1.68) (0.99-1.64) 
84 1.74 1.54C 1.47= 1.68 I.85C 1.65 
(1.32-2.05) (1.19-2.25) (1.04-1.84) (1.17-2.30) (1.49-2.11) 
112 1.99 1.89^ 2.O7C 1.69 2.04^ 1.89 
(1.36-2.38) (1.77-2.07) (1.68-2.17) (0.90-2,18) (1.73-1.97) 
140 2.01 1,90^ 1.97= 1,96 2.13^ 1.96 
(1.56-2.53) (1.65-2,14) (1,60-2,22) (1.74-2.27) (1.79-2.10) 
168 2.04 1.93^ 2,00= 2,02 2.29^ 2.01 
(1.50-2,53) (1,61-2,60) (1.56-2,23) (1,56-2,79) (1.89-2.10) 
Mean 1.53 1.45 1,52 1.59 1.56 
^Groups 1, 2, 4 and 5 ingested 0, 2, 4, 8 and 16 mg lead/kg body weight on a 5 day/week 
regimen for approximately 12 weeks (60 dosage days) beginning at 5 days of age. 
'^Mean and range of values observed from each group, 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
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establishment of a uniform or constant baseline for comparison was 
virtually impossible. It was decided to refine the two previous 
analyses by statistically comparing the mean differences of the con­
trol group from day 5 to day 42 and from day 5 to day 168 with the mean 
differences of each treatment group during those time periods. 
An analysis of mean differences for total protein levels revealed 
no significant differences between the control group and any of the 
four treatment groups over the time periods evaluated. Examination of 
albumin levels in the same manner yielded similar results. 
Changes in Oj-globulin from day 5 to day 168 were consistent in 
all groups, but the F-test, from the analysis of variance of the mean 
differences between the control group and group 3 (PC.06$) and between 
the control group and group 4 (P<.023) from day 5 to day 42, 
indicated significant results. However, group 3 exhibited a decrease 
in «1-globulin level, while group 4 showed an elevation. A lack of 
consistency in the pattern of response indicates that the alterations 
could have been due to chance or random error. 
A similar analysis of Og-globulin levels revealed the following; 
from day 5 to day 168, group 2 (P<.04) and group 3 (P<.07) each differed 
significantly from the control group, but again group 2 levels increased, 
while group 3 levels decreased. However, O^^globulin levels In groups 
4 and 5 also decreased, which may indicate a trend attributable to 
lead. The same pattern developed when mean differences from day 5 to 
day 42 were compared. 
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When comparing mean differences in ^-globulin levels, group 2 
(P<.02), group 3 (P<^0004), and group 4 (P<.008) differed significantly 
from the control group. Again, the pattern was inconsistent with 
respect to levels of lead exposure, because p-globulin levels in groups 
2 and k increased, and in group 3 decreased over time. The p-globulin 
in group 5 increased at the same rate as it did in the control group. 
Similar inconsistencies occurred in the analysis of data covering 
the period from day 5 to day 42. 
No significant differences were detected when comparing altera­
tions in y-globulin levels from day 5 to day l68, as this protein 
increased at a comparable rate in all groups. Each of the groups 
showed a decrement in y-globulin level from day 5 to day 42. 
Compilation of results from several statistical analyses indicate 
that, in most instances, protein levels did not increase or decrease 
in a consistent pattern that might reflect the influence of varying 
levels of lead. Results of protein level analyses were in many cases 
erratic and irregular, over the course of the experiment, and the ob­
served variations in protein concentrations could be attributed more 
to chance, or uncontrolled variation than to the direct effect of 
different levels of lead exposure. 
Normal immunoelectrophoretic patterns (employing adult sheep 
serum) were established to serve as a basis of comparison for immuno­
el ectropho reg rams developed from lamb test sera collected during the 
course of this experimentation. Rabbit anti-whole sheep serum, when 
allowed to react with electrophoresed normal sheep serum yielded 
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numerous arcs of precipitation (Figure 3a). These included an albumin 
band, several and a^-globulin arcs, many p-globulin bands, and 2 
7-gIobulin arcs. 
Serums collected from each individual lamb at 5, 14, 28, 42, 56, 
84, 112, 140 and I68 days of age were analyzed immunoelectrophoretic-
ally using rabbit anti-whole sheep serum and/or rabbit anti-sheep 
y-globulin. Of primary concern was the development of IgG and IgM 
bands since these proteins are the ones which possess major immunologic 
significance. The Immunoelectrophoresis slides seen in Figures 3b and 
3c were utilized to establish the exact location and conformation of 
the IgG and IgM bands of precipitation (purified IgM was kindly supplied 
by Dr. Ralph Heimer, Department of Biochemistry, Jefferson Medical 
College, Philadelphia, Pennsylvania). 
Although sometimes weak and indistinct (almost imperceptible on 
photographs), the IgM arc was observed at 5 days of age in nearly every 
lamb utilized in this experiment; the IgG band was sometimes short and 
weak in the younger lambs. However, as the animals advanced in age, 
the IgG arc increased in length and intensity, eventuating in a pattern 
paralleling that of the normal adult pattern. 
Evaluative comparisons (Figures 4, 5 and 6) of immunoglobulin 
development in lead-exposed and in control lambs, from 5 days of age 
to 168 days of age, indicated no noticeable lead-based impairment, 
alteration, or enhancement in the development of IgG and IgM as assessed 
by inspection of immunoelectrophorograms. There were no significant 
qualitative or semi-quantitative changes noted in the other serum 
Figure 3. Pictures of immunoelectrophoretic slides of electrophoresed 
normal sheep serum or fractions. Arrows indicate IgG arc; 
straight lines indicate IgM arc. 
a. Well, normal sheep serum; trough, rabbit anti-whole 
sheep serum. 
b. Well, normal sheep serum; trough, rabbit anti-sheep 
y-globulin. 
c. Well, purified IgM; trough, rabbit anti-sheep 
y-globulin. 

Figure 4. Pictures of immunoelectrophoretic slides of electrophoresed 
serum from a control lamb. Upper troughs contain rabbit 
anti-whole sheep serum; lower troughs contain rabbit anti-
sheep "y-globulin. Arrows indicate IgG arc; straight lines 
indicate IgM arc. 
a. Upper well, serum from 5-day-old Iamb; middle well, 
serum from l4-day-old Iamb; lower well, serum from 
28-day-old lamb. 
b. Upper well, serum from 42-day-o1d lamb; middle well, 
serum from 56-day-old lamb; lower well, serum from 
84-day-old lamb. 
c. Upper well, serum from 112-day-old lamb; middle well, 
serum from l40-day-old lamb; lower well, serum from 
168-day-old lamb. 
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Figure 5. Pictures of immunoelectrophoretic slides of electrophoresed 
serum from a lead-treated lamb (4 mg lead/kg body weight). 
Upper troughs contain rabbit anti-whole sheep serum; lower 
troughs contain rabbit and anti-sheep y-globulin. Arrows 
indicate IgG arc; straight lines indicate IgM arc. 
a. Upper well, serum from 5-day-old lamb; middle well, 
serum from l4-day-old lamb; lower well, serum from 
28-day-old lamb. 
b. Upper well, serum from 42-day-old lamb; middle well, 
serum from 56-day-old lamb; lower well, serum from 
84-day-old lamb. 
c. Upper well, serum from 112-day-old lamb; middle well, 
serum from l40-day-old lamb; lower well, serum from 
168-day-old lamb. 

Figure 6. Pictures of immunoelectrophoretic slides of electrophoresed 
serum from a lead-treated lamb (16 mg lead/kg body weight). 
Upper troughs contain rabbit anti-whole sheep serum; lower 
troughs contain rabbit anti-sheep y-globulin. Arrows indi­
cate IgG arc; straight lines indicate IgM arc. 
a. Upper well, serum from 5-day-old lamb; middle well, 
serum from l4-day-old lamb; lower well, serum from 
28-day-old lamb. 
b. Upper well, serum from 42-day-old lamb; middle well, 
serum from 56-day-old lamb; lower well, serum from 
84-day-old lamb. 
c. Upper well, serum from 112-day-old lamb; middle well, 
serum from l40-day-old lamb; lower well, serum from 
l68-day-old lamb. 
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proteins. Figures 4, 5 and 6 are representative of all slides ob­
served and photographed. 
Development of Antibody Response 
in Control and Lead-Treated Lambs 
Control and lead-treated lambs were assessed for their ability to 
produce antibodies, after several intravenous injections of a Serratia 
marcescens heat-killed bacterin. None of the 25 lambs displayed pre-
inoculation titers against this organism, but the bacterin did evoke a 
significant response from each animal. Lamb #63, receiving lead at a 
dosage level of 2 mg/kg, died within three hours after receiving its 
initial bacterin injection. Post-mortem examination revealed that 
death resulted from a rapid hypersensitivity reaction. 
Weekly serum antibody titers were obtained from each lamb for 
12 weeks following the initial injection at 6 weeks of age. The weekly 
mean passive hemagglutination titers for each group of lambs are pre­
sented in Table 10, along with overall group- and time-means, plus 
range values. Weekly mean titers are also displayed graphically in 
Figure 7. From examination of the mean values, it is apparent the 
levels of lead employed in this experiment did not impose an immuno­
suppressive effect upon the immune response to Serratia marcescens. 
In fact, the antibody levels on days 7, l4 and 21 were generally higher 
in lead-exposed groups than in the control group. 
Hemagglutination titers began to stabilize and exhibit uniformity 
across all groups at day 35; therefore, only those data obtained from 
sera collected on days 7, l4, 21 and 28 were subjected to statistical 
Table 10. Passive hemagglutination titers for control and lead-exposed lambs at weekly intervals 
following the initial injection of heat-killed Serratia marcescens. Injections occurred 
on the 1st, 3rd, 5th, 7th, l4th and 21st days. 
Passive hemaggutination ti ters^ 
)ays after Group Group Group Group Group Mean 
Initial 1 2 3 4 5 
Injection Control 2 mg/kg 4 mg/kg 8 mg/kg 16 mg/kg 
7 272 420^ 1064 432 192 478 
80-640 80-1280 40-1230 80-640 160-320 
14 272 720^ 1552 992 1540 1027 
80-640 320-1280 80-2560 160-2560 320-5120 
21 384 560^ 800 480 1856 827 
80-1280 160-1280 160-1280 160-640 320-2560 
28 2192 300^ 600^ 496 402 831 
80-10,240 160-1280 80-320 80-1280 160-640 
35 144 160^ 200^ 232 60*) 162 
40-320 80—640 80-320 40-640 40-80 
42 104 65*' 45'' 50 65'' 68 
20-320 80-320 20-80 10-80 10-160 
49 92 50'' 30*) 56 40^ 57 
20-320 20-80 20-40 10-80 40 
56 84 70*^ 20^ 42 60^ 55 
20-320 20-80 20 10-80 10-80 
63 36 48") 20^^ 42 60% 38 
20-80 20-160 20 10-80 10-80 
70 50 45") 20^^ 42 60 42 
10-160 10-80 20 10-80 10-80 
77 52 35^ 20*" 34 60^= 38 
20-160 0-80 20 10-80 10-80 
84 60 35^ 18'^ 28 60*^ 38 
20-160 0-80 10-40 20-40 10-80 
Mean 312 209 4l 1 244 529 
®Mean and range of titers obtained from each group. 
^Four animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
^Two animals/group - adjusted group means were obtained if unequal cell frequencies occurred. 
Figure 7. The comparative long-term antibody response of the control 
group and the lead-treated groups to six injections of 
Serrâtia marcescens received on days 1, 3, 5, 7, |4 and 21. 
Small arrows indicate 0.5 ml injection; large arrows indi­
cate 1.0 ml injection. Each point represents the mean 
passive hemagglutination titer of groups of five lambs. 
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analysis. In order to stabilize the variation which is inherently 
present in titer data because of the wide range between individual 
values, log transformation of the data was deemed necessary before an 
analysis of variance could be conducted. The analysis revealed ro 
significant difference in antibody response among the groups. 
To test for the presence of 7S and 19S immunoglobulins in control 
and lead-exposed lambs during and after exposure to Serrâtia marcescens, 
sera from several individual animals were exposed to 2-ME. Serum 
titers remaining after such treatment were considered to be due to 7S 
antibody, or IgG. Figures 8 and 9 are representative of results ob­
tained by this treatment of sera with 2-ME. Relatively high levels of 
19s antibody (igM) were consistently observed throughout the 84-day 
period following initial injection of the bacterin. This was accom­
panied by appreciable levels of 2-ME-resistant antibody (IgG) until 
titers began to decline, at which time little or no 7S antibody 
remai ned. 
Approximately 60 days post-challenge, each animal received a 
secondary injection of Serratia marcescens. Because lambs #51, #61, 
#71, #81, #52 and #62 exhibited shock-like symptoms (or endotoxin re­
action) shortly after receiving an intravenous secondary challenge, it 
was decided to expose the remaining lambs by the subcutaneous route to 
allow for slower diffusion and absorption of antigen. Individual 
secondary titers are shown in Figure 10 for those animals challenged 
via the intravenous route and in Figure II for those injected 
Figure 8. The effect of 2-mercaptoethanol on serum antibody developed 
in a control lamb injected with Serrâtia marcescens on days 
5 ,  I t  14 and 21. Small arrows indicate 0.5 ml injection; 
large arrows indicate 1.0ml injection. 
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Figure 9. The effect of 2-mercaptoethanol on serum antibody developed 
!n a lead-treated lamb (16 mg lead/kg body weight) injected 
wi th  Serra t ia  marcescens on days 1 ,  3 ,  5,  7,  l4  and 21.  
Small arrows indicate 0.5 ml injection; large arrows indi­
cate 1.0 ml injection. 
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Figure 10. Secondary antibody response of six individual lambs to an 
intravenous injection of Serratia marcescens approximately 
60 days after the primary series of injections was completed. 
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Figure 11, Secondary antibody response of fourteen individual lambs to 
a subcutaneous injection of Serratia marcescens approximately 
60 days after the primary series of injections was completed. 
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subcutaneous]y. All lambs exposed intravenously responded with an 
increase in antibody titer regardless of group. Although the rise 
in antibody level was not as marked in those lambs challenged by the. 
subcutaneous route, all but two responded to the secondary injection. 
The lambs were not being treated with lead at the time of secondary 
injection, but those animals in the exposed groups were all manifesting 
residual blood lead levels above the normal range. 
DISCUSSION 
A recent study clearly demonstrated that mice exposed to non lethal 
levels of lead for 30 days were more susceptible to a pathogenic strain 
of Salmonella typhimurium than were their normal counterparts (Hemphill 
et al., 1971). Although there have been no subsequent reports of a 
similar phenomenon occurring in other mammalian species, numerous indi­
viduals have speculated on the effects which lead might impose on the 
various mechanisms of the immune response. Thus, these ideas and hy­
potheses are generally based on analysis of the literature relative to 
heavy metals and their overall effect upon biological systems, rather 
than on original research. 
It is quite possible that lead may interfere with specific immunity 
(synthesis and/or mobilization of antibodies) by (1) causing cytopathic 
effects in lymphoid tissues and in other cells which are requisite to 
antibody formation; (2) binding to and/or hydrolyzing nucleic acids which 
may be essential to induction of antibody synthesis; or (3) depressing 
immune mobilization through complexing (binding) antibodies already in 
the circulation. Lead may also impose adverse influences upon innate 
or natural immune factors. For example, since it is known that certain 
enzymes are very sensitive to lead exposure (Tepper and Pfitzer, 1970), 
it is possible that lead could interfere with the enzyme systems neces­
sary for immunologic activities of complement and also with those 
enzymes which come into play during phagocytosis of harmful micro­
organisms. 
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As previously mentionedJ there are multitudinous reports relative 
to the pathological and other biochemical effects of lead, but studies 
dealing with immunological changes associated with lead exposure have 
been sparsely documented. The variability and complexity of inter­
actions involved in the immune system negated the possibility of test­
ing and evaluating the effect of lead on every known factor involved 
in the development of immunity in young sheep. Therefore, this investi­
gation was launched with two specific goals in mind; first, to conduct 
an exhaustive survey and comparison of serum protein levels in normal 
and lead-treated lambs from 5 days to 6 months of age, with special 
interest directed toward the development of major immunoglobulin sub­
groups, and secondly, to study the development of specific immunity in 
control and lead-treated lambs after they had been exposed to a known 
antigenic stimulus. 
Levels of oral lead exposure were established with the aid of a 
recent investigation by Sharma (1971) who reported overt toxicosis in 
12 ewes which had ingested 11.8 mg lead/kg body weight for approximately 
45 days. It was initially projected that the force-feeding of several 
graded doses of lead to the lambs would be continued for a period of 
6 months, in an effort to produce varying rates of lead absorption, in 
other words, it would have been desirable to develop graded pathologi­
cal states, e.g. (1) several lambs with increased blood lead levels, 
but no metabolic or functional symptoms; (2) others exhibiting altered 
metabolites in the blood and urine, but no obvious functional injury; 
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(3) a group of animals which displayed functional anomalies of the 
kidneys, hemopoietic system, and central nervous system; and (4) a 
group manifesting acute toxicity. 
However, after 10-11 weeks of lead encounter, several lambs began 
to express motor clumsiness, lassitude, anorexia, and gastrointestinal 
irregularities. Before the syndrome could be properly treated, three 
lambs in the highest exposure group succumbed to irreversible lead 
poisoning. In order to standardize the period of exposure across 
groups and to reduce variability when evaluating experimental data, all 
lambs were removed from the lead regimen at approximately 12 weeks of 
age. Each of the exposed lambs continued to manifest elevated blood 
lead levels throughout the 6 months of observation; and since it has 
been established (Chisolm, 1971) that many residual effects persist even 
after blood lead levels return to normal, collection of serum samples 
was continued on a weekly basis throughout the entire period. 
Serum proteins in vertebrates are indeed a diverse group manifest­
ing a wide variety of functions, including maintenance of plasma pH, 
colloid pressure, and viscosity; transportation of various substances 
of exogenous and endogenous origin; and regulation of cellular activity 
and function. Along with the immunoglobulins, which possess the primary 
function of endowing the body with a defense against infection and injury, 
many other serum proteins wield a role of prominence as overall effectors 
and mediators of immunity. For example, it is conjectured that trans­
ferrin, the principal p-globulin of serum, may serve as a compensatory 
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defense mechanism in some instances because of its capacity to assert 
a suppressive effect on the growth of certain microorganisms (Turner 
and Hulme, 1971). 
Complement, a\complex group of enzymes, which is present in the 
a-, p-, and y-globulin fractions, also merits mention in this dis­
cussion. It functions harmoniously with antibodies and plays a highly 
significant role as a mediator of immune and allergic reactions (Mayer, 
1973). Various components of this effector system serve numerous bio­
logic functions which include potentiating phagocytosis, mediating 
immune adherence, increasing vascular permeability, augmenting 
neutrophilic chemotaxis, and destroying bacteria. Gewurz (1971) has 
discussed virus neutralization, mediation of graft rejection, destruc­
tion of neoplastic cells, and participation in immediate and delayed 
hypersensitivity as other immunologic phenomena which might be affected 
by complement; worldwide research is underway to completely explore 
these areas. Investigators have also discovered that complement medi­
ates a definite interaction between clotting mechanisms and host de­
fense responses (Ratnoff, 1971). The revelation of this relationship 
has been helpful in studying idiosyncratic reactions to drugs, mechan­
isms of endotoxic shock, and rejection of organ transplants. Based 
upon this discussion, it becomes immediately clear that If lead incites 
modification or instability of consequence in these physiologic compc 
nents, it is quite possible that defense mechanisms may be significantly 
disrupted. 
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In comparing control and lead-treated lambs^ this study revealed 
some statistically significant alterations in concentrations of albumin, 
«j-globulin, O^-Qlobulin, ^-globulin, and y-globulin. However, there 
was seldom a pattern of consistency developing in response to different 
levels of lead. There were some trends in the data which may or may 
not have signified a direct effect of lead. Perhaps if greater numbers 
of animals had been employed in this study, the data would have been 
less confusing and the trends would have been more readily understood. 
Total protein levels tended to increase in all groups from day 5 
to day 168. This observation was not considered abnormal because in 
many species total protein levels manifest an appreciable gain with 
increasing age. The marked variability across all groups from day 42 
to day 84 may be attributable to numerous factors, e.g. weaning of 
lambs, exposure of lambs to antigenic stimulus, or termination of lead 
exposure. The only report in the literature contradictory to the find­
ings of this investigation was that of Cervetti and Casucci (I960) who 
indicated a significant decrease in total serum protein in several 
humans suffering from severe lead poisoning. 
This research endeavor disclosed relatively little change in 
albumin levels among control lambs and lambs exposed to various levels 
of lead. Rather, there was a trend of slight increase in albumin with 
increasing age, in all groups. These finding do not appear consistent 
with those of Kapetanovic ^ (I960) who studied persons suffering 
from chronic lead poisoning, or with those of Hayashi £t £l_. (1959) who 
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reported on lead poisoning in rabbits, as they both reported a signifi­
cant diminution in the albumin fraction of their subjects. 
Soliman ^ aj_. (1970) reported a decrease of a-globulins in 
several Egyptian lead workers, while Cervetti and Casucci (I96O) docu­
mented an enhancement in these fractions. The animals surveyed in this 
project did not manifest meaningful deviation in 0^-globulin values 
throughout the experimental period; the changes which did occur could 
not be associated with the presence or absence of lead. A trend which 
merits consideration occurred in the o^-globulin concentrations. Groups 
3 and 4, which received 4 mg lead/kg body weight and 8 mg lead/kg body 
weight, respectively, when compared to the control group manifested a 
rather marked decrease in the ag-globulin component. However, the mean 
values for the group exposed to the highest level of lead did not dis­
play such a dramatic decrease, and those animals which received 2 mg 
lead/kg body weight generally showed an enhancement of C^rglobulin over 
the 6 months time period. Although these results may be interpreted to 
mean that lead was asserting a suppressive effect of some nature on the 
Og-globulin component, the assumption would not be a firm one. 
A general increase in the p-globulin component was demonstrated in 
the control group and in all treatment groups except group 3 (4 mg 
lead/kg body weight), which showed a slight decrease. Cervetti and 
Casucci (i960) reported this fraction to be enhanced beyond the normal 
range in lead-poisoned humans. 
Each group of lambs exhibited a depression in mean y-globulin 
levels from day 5 to day 42, with a marked decrease noted in group 4 
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(8 mg lead/kg body weight) from day 5 to day 42. A possible expla­
nation for this phenomenon would be a reduction in maternal antibodies 
(obtained in the colostrum) as the lambs progressed in their develop­
ment and their periods of nursing became shorter and less frequent. 
There appeared an increase in the antibody globulin at day 56, which 
continued throughout the remaining period of evaluation. This is 
probably reflective of the artificial antigenic stimulation which began 
at approximately 42 days of age. Also, as an animal increases in age, 
there is naturally more exposure to exogenous stimuli accompanied by a 
tendency to develop subclinical infection, which would probably result 
in an enhancement of y-globulin. 
It has been documented that after an animal Is weaned, it will mani­
fest lower concentrations of serum proteins than does its adult counter­
part. The protein components, then, usually increase in concentration 
as the animal becomes older (Dimopoullos, 1963). Some of the observa­
tions made during the course of this study are probably a reflection of 
this normal pattern of events. 
Several heavy metals possess the potentiality to interact with 
proteins, nucleic acids, or integrated systems such as organelles. 
Wi 11 iams et £l^. (1954) reported the in vitro precipitation of y-globulin, 
and subsequently speculated on the likelihood of a similar phenomenon 
occurring in a living physiological system. Albumin is particularly 
susceptible to metal binding. Bryan and Bright (1973) reported a 
depression in several serum proteins after short periods of exposure 
to nonfatal levels of cobalt. Mercury, on the other hand, was found 
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to produce an immediate enhancement of several globulin components. 
The same investigators have suggested a form of protein induction-
repression mechanism to be responsible for metal-induced variations 
in serum protein patterns. In other words, an interaction between 
metals and specific enzymes might influence the rate of accumulation 
and/or removal of the protein components. 
Based upon the results of serum protein quantitation in lead-exposed 
sheep, lead apparently did not exert an effect of the nature just de­
scribed (unless possibly in the case of the a^-globulin component). 
However, there is the possibility that the sheep developed a rapid 
tolerance to nonlethal quantities of lead through some adaptive process. 
Although reporting results thgt were often contradictory, a few 
previous investivators have indicated "significant" alterations in serum 
protein levels for various species exposed to lead compounds; therefore, 
it seemed somewhat surprising that such phenomena could not be more 
readily detected. The weakness of many reports is that even when changes 
did occur in serum proteins, lead could not be positively incriminated 
as the responsible agent. This investigator feels that there is a 
tenable explanation for the inconsistencies which appear in the litera­
ture relative to the effect of lead on serum protein components. Inter­
pretation of data obtained from electrophoregrams must be undertaken 
with extreme caution because serum protein profiles may be altered by 
numerous pathological, physiological, and experimentally-induced stress 
factors. It is important to look for abrupt alterations or gradual 
trends which occur with consistency in animals within a given treatment 
69 
group or groups, if using this as a means to determine the effects of 
a toxic substance. Of course, the appearance of new components, or 
the absence of normal fractions, may indeed be diagnostic, if related 
to a specific treatment. 
Also, it appears as though many investigators, when interpreting 
quantitative serum protein data, fail to accept the fact that there is 
a wide range of values which are considered normal in a given species. 
Thus, in order to attain more precise and accurate evaluations of such 
parameters, biological variation must be drastically reduced, e.g. a 
homogeneous group of well-defined animals (sex, genotype, weight, and 
age) should be obtained, and the experimentation should be well-con­
trol led in regard to environment, husbandry, nutrition, and exposure to 
pathogenic microorganisms. Lack of sufficient numbers of subjects is 
another inherent defect in most research endeavors of this kind. Dis­
crepancies and inconsistencies in results would probably be reduced if 
it were economically feasible to utilize more animals. 
Serum samples from control and lead-exposed lambs were further 
analyzed by the technique of immunoelectrophoresis, using commercial 
antisera prepared against normal sheep serum and against normal y-
globulin. Although I was interested in all antigenic components, of 
which there are 23 in sheep serum, as reported by Chordi and Kagan 
(1964), this was primarily an attempt to follow and compare the develop­
ment of immune globulins among the various groups of lambs, noting time 
and sequence of appearance and intensity of precipitin bands. 
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Immunoglobulins of all mammalian species studied have been divided 
into several classes on the basis of molecular weighty electrophoretic 
mobility, and chemical and immunological properties of their heavy 
chains. Five immunoglobulin subgroups have been defined thus far in 
sheep. There are two antigenically related 7S immunoglobulins desig­
nated as IgGj (fast component) and IgGg (slow component), which usually 
present a "gull-wing" shape on itnmunoelectrophoretic slides, and there 
is a component analogous to human IgM (Aalund et , 1965, Heimer at al.. 
1969, and Sullivan 1969). Lascelles and McDowell (1970) iso­
lated IgA from mucous secretions of ewes, but there is only circum­
stantial evidence that IgA exists in sheep serum. A component desig­
nated as IgGj^ has also been described (Curtain, I969), but this sub­
group is definitely lacking in serum of some sheep. Only the IgC^, 
IgGg, and IgM components are resolvable and easily identified on Immuno­
electrophoresis slides. 
Although the ovine animal does not receive immunoglobulins from 
the maternal circulation via the placenta, it has been established by 
Silverstein e^ (1963a) that the fetal lamb is not agammaglobulinemic. 
Their study demonstrated that, in utero, the unstimulated lamb does 
engage in the production of IgM, along with small amounts of IgG. There­
fore, it seemed highly probable that the IgM and IgG subgroups would be 
detectable in the lambs at day 5, and therefore should be observable 
throughout the entire experimental period unless lead was affecting 
both components, or possibly interfering with one immune fraction 
preferentially over the other fraction. 
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These studies indicated no existence of significant qualitative 
or semi-quantitative differences in the immunoelectrophoretic patterns 
of immunoglobulins (IgG and IgM) obtained from control and lead-exposed 
lambs for a 6 months' period. It appears that lead, at the concentra­
tions employed, neither removed the serum immunoglobulins from the 
circulation, nor impaired their development. 
Although Belli et £l_. (1955a, 1955b, and 1955c) found that rabbits 
that had been poisoned with tetraethyl lead via the subcutaneous route 
were less capable of producing antibodies against bacterial antigens 
than were normal rabbits, and Hemphill (1973) reported a similar 
phenomenon in mice exposed to intraperitoneal lead nitrate, the results 
of this present study were not in agreement with those findings. In 
fact, upon exposure to heat-killed Serratia marcescens, the lambs which 
had ingested lead for several weeks, in many instances, responded 
immunologically more promptly and efficiently than did their normal 
counterparts. 
However, when comparing contradictory results such as these, many 
factors must be taken Into consideration, such as species of animals 
utilized, and their relative susceptibilities to lead. Even animals 
of the same speciation may individually differ in their tolerance to 
this heavy metal, such has been observed in the porcine animal (Lassen, 
1973).' Also, the route of administration and dosage level of lead 
used are important. For example, Hemphill (1973) demonstrated a 
'Lassen, E. D., Department of Pathology, College of Veterinary 
Medicine, Iowa State University, Ames, Iowa. Information concerning 
biochemical effects of lead in swine. Personal communication, 1973. 
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reduction in antibody response, but his animals were receiving either 5 
ppm or 12 ppm of lead injected into the peritoneal cavity, whereas the 
lambs which I used received 2 ppm, 4 ppm, 8 ppm and 16 ppm via the oral 
route; the percentage amount of lead absorbed through the intestinal 
tract after oral ingestion remains undefined. Finally, blood lead 
levels, per se, may not be highly correlated with the toxic effects 
of lead; it is really more significant to know the amount of lead which 
is in the interstitial tissues. For example, those animals which retain 
high concentrations of lead attached to their red blood cells may mani­
fest high blood lead values, but other individuals which bind less lead 
in their blood cells and release soluble lead into the soft tissues of 
the body may be more debilitated. Conversely, Sharma (1970 has shown a 
high correlation between blood lead levels and toxic signs in adult sheep. 
In this study, the lambs were allowed to reach 6 weeks of age be­
fore being exposed to a test antigen. Therefore, those lambs in the 
lead-treatment groups had received lead for several weeks prior to 
initiation of their immunization series. Serratia marcescens was used 
as the standard antigenic stimulus because it is a rather innocuous 
organism, and is not normally considered part of the normal microflora of 
sheep. It was assumed that there would be no pre-existing antibody 
titers against this antigen to interfere with our immunological evalu­
ation, as was later proven to be the case. Also, elicitation of a 
febrile response or any other clinical symptoms would have been unde­
sirable in this study; therefore, sheep pathogens were purposely 
avoided in the selection of a test antigen. 
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A rather protracted series of antigen injections was imposed, be­
cause antigenic stimulants are often more effective when given in 
several divided doses. There was a concerted effort made to reach 
maximum antibody titers so that additional injections would have little 
or no effect on peak antibody level. However, it was conjectured that 
hyperimmunization might have masked part of the true toxicity picture 
by production of excess immunoglobulins which combined through sulfhy-
dryl groups with heavy metals, thereby overcoming subtle effects of 
lead. 
Potential immunocompetence of the 6-week-old lamb was given partic­
ular consideration before beginning the series of injections. It was 
reported by Si Iverstein et (1963b) that stimulation of the immature 
lamb in utero by a variety of antigens induces, in the fetus, an active 
antibody response. Another research endeavor clearly demonstrated that 
both the fetal, and the newborn 1amb, presumably insulated from anti­
genic stimuli, are actively engaged in the production of at least one 
of the ovine gamma globulins customarily associated with immunologic 
function (Si 1 verstein et ^., 1963a). Therefore, it was assumed that 
these 6-week-old animals would be completely immunocompetent and able 
to respond to an artificial exogenous stimulus, not depending on 
passively conferred maternal antibodies for immunity. 
As the graph displaying mean antibody titers (Figure 7) indicates, 
a latent, or lag, period in immune response was virtually nonexistent 
for all groups. This apparent irregularity may be explained by the 
fact that the animals had already received three injections before the 
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Initial serum samples were obtained; generally a secondary immune 
response can be anticipated within two days after intravenous injection 
of a particulate antigen, such as the one employed in this study. 
Apparent duration of the latent period also depends upon the sensi­
tivity of the method used to detect it. Passive hemagglutination is 
an extremely sensitive assay procedure (e.g. 1,000 times more sensitive 
then precipitin reactions). 
The mean hemagglutination titers are grouped closely together on 
the graph (Figure 7), indicating that there was no great disparity in 
the response of the various groups to this particular antigenic stimu­
lus. It is interesting to note that these results, with the control 
group consistently displaying the lowest mean titer on days f, 14 and 
21, were in accordance with data obtained from a previous Investigation 
in this laboratory. In that study, two groups of ewes receiving, re­
spectively, daily oral dosage of approximately 4.5 and 2.3 mg lead/kg 
body weight for several weeks, manifested consistently higher titers 
to Serrâtia marcescens than did control ewes (Hoffman, 1972).' 
It should be pointed out that, on day 28, while the treatment groups 
had previously reached their maximum titers and were beginning to de­
cline even after an additional injection, the mean response of the con­
trol group manifested a marked increase. This enhancement of response 
carries little significance because there was one individual lamb whose 
Hoffman, L. J., Department of Bacteriology, Iowa State University, 
Ames, Iowa. Information concerning effects of low level lead ingestion 
in ewes. Personal communication, 1972. 
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hemagglutination titer catapulted to over 10,000 after the final in­
jection, thus altering the mean drastically. The decline which was 
detected in the mean titers of the lead-treated groups, even after 
an additional injection of antigen, may have been caused by immune 
exhaustion, a phenomenon in which memory cells, or immunocytes, are 
unable to continue responding, or by feedback inhibition, where pre­
existing specific antibody molecules themselves interfere with initia­
tion of synthesis of this specific antibody. 
It is important to comment on the individual response of Individ­
ual lambs to the test antigen. For example, the control group harbored 
one lamb which was an excellent responder, but the others in this group 
were immunologically sluggish, with sera of two animals not manifesting 
hemagglutination titers beyond l60. However, none of the sera of lead-
treated animals were below a maximum titer of 320, only four out of 19 
were below 640, and sera of 10 of the 19 lead-treated lambs reached a 
titer of 1280, or above. Could it be possible that substances, which 
are lethal or toxic at certain concentrations in the body, may actually 
be stimulatory, at lesser concentrations, to various physiologic factors 
or functions? in the case of lead exposure, perhaps there was an increase 
in cellularity of tissues responsible for antibody formation. In support 
of this explanation, Zarkower and Morges (1972) demonstrated an enhance­
ment of antibody-forming cells in the mediastinal lymph nodes of mice 
after four days' exposure to carbon dust. 
Under the conditions of this particular experimental study, lead 
apparently did not interfere with the functions of the reticuloendothelial 
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system (RES); therefore, the capacity of RES to direct antibody in­
duction, synthesis, and mobilization was not impaired. Also, since 
there were no marked depressions in antibody response among the lead-
treated groups, there is good indication that immunoglobulin molecules 
retained their integrity (no binding or separation of polypeptide 
chains) after reaching the circulatory system. 
In order to determine whether lead influenced either the appear­
ance or disappearance of high and/or low, molecular weight immuno­
globulins formed in response to the Serratia marcescens bacterin, sera 
from the control lambs and from several of the treated lambs were ex­
posed to 2-ME, Lead apparently did not interfere with the production 
of either 7S or 19S antibodies nor did it preferentially affect the 
serum levels of these immunoglobulins, because the results of this test 
were essentially the same for all lambs evaluated. 
Although Field jet al_. (1970) demonstrated no significant amounts of 
2-ME-resistant antibody (igG) appearing in sera of mice injected with 
Serratia marcescens, the present study revealed the presence of both 
7S and 19s antibody. However, at no time did IgG appear to be the pre­
dominant immunoglobulin, as is most often the ca^e in responses to 
bacterial stimuli; IgM usually predominates during the early stages of 
an immune response, only to be outclassed by IgG after a short time in­
terval. This observation may be explained by the fact that gram nega­
tive organisms often elicit predominantly I9S antibody. Also, I9S anti­
body is a more efficient mediator of passive hemagglutination; thus. 
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perhaps more 7S antibody was present, but was not detected with our 
assay procedure. 
• There is no documentation in the scientific literature relative 
to the effect of lead on the secondary or "anamnestic" response to an 
antigenic stimulus. This phenomenon refers to the antibody production 
obtained with a subsequent injection of the same antigen, at a consider­
able interval after the preceding injection or injections, usually as 
titers are decreasing to just above detectable levels. The secondary 
response is characterized by the following: (1) rapidly rising titer, 
(2) peak titer attained which is usually greater than that obtained in 
the primary response, and (3) an antibody titer attained which persists 
for a longer period of time than the primary titer. 
The true scientific value of this phase of the experiment is sub­
ject to question. First of all, the treated lambs had received no 
lead for several weeks prior to secondary injection; therefore, it was 
impossible to reach positive conclusions concerning the response of 
lambs to a subsequent stimulus while concomitantly receiving lead, which 
had been the case during the primary injection period. Also, there was 
variability introduced by using two different routes of exposure. 
There were only two animals, both of which were exposed by the 
subcutaneous route, which did not manifest an elevation In antibody 
titer after secondary stimulation. Much as expected, the intravenous 
injections elicited a more marked response; each lamb exposed through 
the jugular vein matched or surpassed its previous high titer. 
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Evidence that residual lead affected the lambs' response to 
secondary antigenic exposure did not exist. Although the intensity of 
response did vary among the animals receiving an injection via a com­
mon route, the within group variations were often greater than the 
differences between the groups. 
In conclusion, this study indicated that various selected levels 
of lead ingestion (generally "^subclinical" in nature) caused no major 
qualitative or quantitative alterations in serum proteins of treated 
animals, including the immunoglobulins, and no significant difference 
in antibody response was noted between control and lead-exposed lambs. 
Under certain circumstances, of course, lead is a highly toxic metal; 
however, there were no outstanding upsets in the humoral defense system 
of the normal, healthy lambs which were evaluated here. It must be 
remembered that this response pattern may not be true under another 
set of experimental conditions, or for other species. For example, the 
immune competence of disadvantaged children suffering from vitamin and 
mineral deficiencies may be altered significantly after accidental ex­
posure to relatively low quantities of lead. 
These results obtained with sheep do not necessarily concur with 
all previous reports on the effects of exposure to subclinical dosage 
of lead, but may be explicable in a number of ways; however, one can 
only speculate on why immune responses of lambs were not impaired, 
altered, or enhanced by exposure to lead. Perhaps the lead molecules 
did not progress to a site or sites which would be critical for induc­
tion of immunological mechanisms; therefore, adverse changes were so 
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inconsequential that they went undetected. Also, it is possible that 
temporary abnormalities were produced, but were easily repaired by 
normal bodily mechanisms, with no resultant lasting effects. Finally, 
it is conceivable that these lambs may have possessed the capacity to 
detoxify (tolerate) the prescribed dosages through physiological mechan­
ism inherent in sheep. 
This study is extremely significant from a practical point of view, 
because a random heterogeneous population of animals was used, which is 
representative of sheep in commercial production. Also, results of 
lead exposure obtained in this study seem to be more extrapolatable to 
human populations than are those results obtained in several earlier 
studies because (1) blood lead levels were in a range which is not un­
usual for children exposed to excessive quantities of lead, and (2) a 
normal route of exposure was employed, in contrast to the abnormal 
process of subcutaneous, or intravenous, injection. 
This research project definitely points out the need for more in­
formation in the area of heavy metal effects on immune response mechan­
isms. First of all, consideration must be given to developing more 
realistic and sensitive models for natural exposure to this substance. 
Since one of our major concerns is how atmospheric lead affects the 
health of living populations, it would seem logical to study the long-
term effects of inhaled lead by simulated exhaust fumes, etc. in experi­
mental inhalation chambers. Perhaps the antigen should also be intro­
duced by the aerosol route to determine exact effects of lead on the 
respiratory defense system. It is imperative that more quantitative 
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information be obtained relative to how lead affects antibody-forming 
cells, lymphoid organs, and various classes of immunoglobulins. A 
long-term study to evaluate the possible differences between genotypes 
in relative susceptibility to lead should be given consideration in 
the future. 
Finally, it is most important that we remain mindful of the com­
plexity which is inherent in biological systems. In our attempt to 
make research more manageable, we often tend to isolate, or oversimplify, 
components of physiology. Nothing biological operates with a single 
variable, and the immune response system is no exception. Resistance 
to bodily stress encompasses a number of defense mechanisms, whose 
responses are mobilized by an intermeshing of numerous physiological 
systems. 
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SUMMARY 
Twenty-five lambs of Columbia-Rambouilet cross were divided into 
five equal groups which received 0, 2, k, 8 and 16 mg lead/kg body 
weight, respectively, via the oral route. Ingestion of lead, in the 
form of solubilized lead acetate, was permitted on a daily basis (5 
days/week) for 12 weeks. This period of ingestion resulted in mean 
blood lead levels of 11.7, 37.2, 56.8, 67.6 and 99 |ig/100 ml, respec­
tively, over the 6-months' evaluation period. Nearly every lamb in 
each of the treated groups continued to manifest significantly high 
blood lead residues (as compared to those Iambs in the control group) 
after lead exposure was terminated. 
Cellulose acetate electrophoresis and agar gel Immunoelectrophoresis 
were used to examine serum protein patterns at regular intervals, start­
ing when the lambs were 5 days of age and continuing until they were 6 
months old. Although statistical analyses of absolute concentrations 
of total protein, albumin, 0^-globulin, O^'Slobulin, p-globulin and 
y-globulin detected significant differences among groups in certain 
instances, there was little basis for concluding that these alterations 
were an effect of increasing levels of lead and not due to uncontrolled 
variations, or random error in the experimentation. However, certain 
trends seemed evident (from time to time) which perhaps would be more 
pronounced if the number of subjects in each treatment group had been 
larger. There were no detectable differences noted among groups in 
the development and maintenance of immunoglobulin subgroups, IgG and 
IgM, as evaluated by electrophoresis precipitin patterns. 
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The various treatment groups were also compared in their responses 
to injections of heat-killed Ssrratia marcescens. There were no sig­
nificant differences noted in passive hemagglutination titers among 
treatment groups, but during the actual period of immunization, the 
lead-treated groups consistently displayed higher serum titers than 
did the control group. 
Of the immunologic parameters investigated in this study, none 
were consistently affected by the selected levels of oral lead exposure. 
Under these research conditions, one could conclude that lead does not 
impose a state of immunologic deficiency in the ovine species by altering 
antibody synthesis or mobilization of preformed antibody, nor by inter­
fering with the production or maintenance of serum proteins. 
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APPENDIX 
Serum Protein Electrophoresis 
A. Reagents 
1. Buffer: Tris-barbital (Gelman Catalog #51104) 
Dissolve I packet of High Resolution Buffer in distilled 
water and dilute to 1000 ml, pH 8.8, ionic strength 0.05. 
2. Stain: Ponceau S (Dye II, Buchler Catalog #3-1133) 
3. Decolorized: Acetic acid 
Prepare 300 ml (3 trays, 100 ml each) of 5% aqueous 
acetic acid (v/v). 
B. Procedure 
1. Preparation of electrophoresis chamber. 
Place chamber on a level, firm surface and fill the chamber 
with Tris-barbital buffer. Attempt to obtain equal levels 
in all compartments. 
2, Preparation of cellulose acetate strips (Beckman cellulose 
acetate manufactured by Hillipore Filter Corporation, 
#324330, Size 57 x 145 mm. 
a. Label the strips at one end using nondiffusibie ink. 
b. Float the strips on the buffer surface until they are 
completely wetted and then immerse them. 
c. After a thorough wetting has been effected, remove 
the membrane from the buffer and blot dry between two 
pieces of filter paper until all excess moisture is 
removed. 
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d. Each strip is then stretched across a plastic bracket 
which is in turn positioned in the chamber with the 
ends of the strip submerged directly in the buffer. 
Application of samples. 
a. Using the microzone sample applicator pick up the 
serum sample, making sure that the sample is in a 
continuous film across the length of the applicator 
wi re. 
b. On the cathode side of the chamber, place the appli­
cator over the strip in the position and press the 
applicator button down to apply the sample. Clean 
and rinse applicator wire between each sample. 
Electrophoresis of samples. 
a. Place cover on chamber. 
b. Connect tank to power supply and set it at 250 v. 
c. Turn on power supply and allow separation to continue 
for 25 mi n. 
d. Turn off power supply and disconnect the chamber. 
Staining of strips. 
a. With blunt-tipped forceps, remove the cellulose-
acetate strips from the chamber. 
b. One at a time, float the strips in Ponceau S solution. 
When the strip is completely wet, immerse It, and 
stain for 5-10 min. 
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c. Decolorize the stained strips by rinsing successively 
in 3 baths of 5% acetic acid, until background Is 
white. 
d. After blotting between paper toweling, the membrane 
should be pressed flat until completely dry. 
6. Evaluation of stained strips. 
Integrated electrophoretic density plots were obtained 
with a scanning densitometer. 
Immunoelectrophores i  s 
A. Reagents 
1. Buffer; Tris-barbital (Gelman Catalog #51104) 
Dissolve 1 packet of High Resolution Buffer in distilled 
water and dilute to l800 ml, pH 8.8, ionic strength 0.05 M. 
2. Agar: Noble Agar (Difco Catalog #0142-01-8) 
Weigh out I 1/2 g of Noble Agar and suspend it in 50 ml 
distilled water plus 50 ml of Tris-barbital buffer. Add 
several drops of merthiolate preservative (1 ;10,000=final 
concentration). Heat in a water bath until solution is 
completely clear. 
B. P rocedu re 
I. Preparation of agar-covered slides. 
a. Load each immuno frame (Gelman Catalog #51447) with 
6 25 mm X 75 mm glass slides. 
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b. Place the spirit level within the engraved circle in 
the center of the leveling table, (Gelman Catalog 
#51^33) and adjust the table until the bubble is in 
the proper position. 
c. Secure 3 loaded immuno frames between the clamping 
bars on the leveling table. 
d. Fill the small depressions at either end of the 
immuno frames with warm agar. Proceed to cover the 
slides until each half of each frame contains 12 ml 
of the warm agar in a uniform layer. Place the level­
ing table cover over the coated plates and allow to 
set for 30 min. 
e. Prepare a humidity chamber by placing wet paper towel­
ing In the bottom of a rinsing tray. 
f. After the agar has set, place the frames into the 
immuno frame holder (Gelman Catalog #51448) and put 
into the humidity chamber. Allow the slides to re­
main in the chamber overnight. 
2. Pattern cutting and application of serum samples. 
a. After removing the frames from the humid atmosphere 
chamber, the gel punch (Gelman Catalog #51449) is 
positioned over the frame. By moving the punch along 
the frame and applying pressure at the appropriate 
times, a pattern consisting of troughs and wells is 
thus punched out in the gel layer of each slide. 
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b. Suck out the plugs of agar remaining in the wells 
with a fine-tipped micropipette connected to an 
aspi rater, 
c. Place the serum samples to be analyzed in the wells 
with a fine-tipped micropipette. 
Electrophoresis of samples. 
a. Fill the chamber (Gelman Catalog #51211) with buffer 
solution. 
b. Place the frames across the chamber. 
c. Saturate 4 strips of filter paper per frame in 
buffer solution; place wicks in chamber, one end on 
agar and opposite end in the buffer solution. 
d. Place cover on chamber, and connect chamber to power 
supply. 
e. Electrophorese for 120 mi n at 3-5 ma per frame (12 
ma; 200 v when running 3 frames simultaneously). 
Development of precipitin patterns. 
a. Remove gel from troughs with the gel knife (Gelman 
Catalog 451480). 
b. Place approximately 0.15 ml of the appropriate anti­
serum into the trough and spread evenly. 
c. Incubate for 16-20 hr in a humidity chamber or until 
the lines of precipitation have completely developed. 
d. Rinse the slides for 2 days in 2 different solutions 
of 2% NaCl. 
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e. Rinse for a short time in distilled water to remove 
all residual unreacted serum and antiserum. 
5. Photographing precipitin patterns. 
Precipitin patterns are photographed using a special viewer 
box which employs indirect lighting. Converging rays of 
light are allowed to strike the slide which is then photo­
graphed against a dark background. 
Passive Hemagglutination Test 
A. Reagents 
1. A1sever's Solution 
a. Solution A: dextrose, 20.5 g; sodium citrate, 12 g; 
sodium chloride, 4.2 g; triple distilled water, q. s. 
to 100 ml. 
b. Solution B: citric acid, 1 g; triple distilled water, 
10 ml. Adjust pH of Solution A to 6.1 using the citric 
acid solution. Multiply the amount of citric acid 
required to attain the above pH x 49; add that amount 
of citric acid to Solution A. 
c. Filter sterilize using 0.2 (j,millipore filter. 
d. Store in the refrigerator as a lOx solution. Add 
20 ml of stock solution to 180 ml of sterile distilled 
water to obtain the final concentration (working 
solution), 
96 
2. Endotoxin (Dykstra, personal communication) 
a. Suspend Serrât I a marcescens 11popolysaccarlde W 
(DIfco Catalog #3130-25) In 0.85% NaCl to a concentra­
tion of 10 mg/ml. 
b. Add 4.5 ml of 0.25 N NaOH to this suspension of endo­
toxin (1 ml), and Incubate In a 37 C water bath for 
3 hr. 
c. Neutralization of the endotoxin solution is accomplished 
by adding 4.5 ml of 0.25 N HCl after the 3 hr incubation 
period. 
d. Divide the final solution Into 2 ml aliquots and store 
In vials at -20 C until needed. 
B. Procedure 
1. Preparation of sheep red blood cells. 
a. Collect sheep REC in Alsever's Solution (equal volumes 
of each). 
b. Wash and centrifuge RBC 3 times In 0.85% NaCl at 600 x g 
for 10 min. 
c. Add 0.25 ml RBC to 1 ml Serrât la marcescens endotoxin 
solution, and Incubate this mixture in a 37 C water 
bath for 30 mln. 
d. Wash and centrifuge treated cells to remove excess 
endotoxin. Repeat washing step 3 times, 
e. Resuspend cells In PO^-buffered saline, pH 7.2, to 
yield a final concentration of 0.5% (v/v). 
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Preparation of antiserum. 
a. Thaw serum in 37 C water bath; remove 1 ml aliquots 
and inactivate by incubating in water bath at 56 C 
for 30 min. 
b. Dilute serum 1:5 with 0.85% NaCl. 
Preparation of 1% normal rabbit serum. 
a. Thaw serum and inactivate as in part 2. 
b. Absorb serum with equal volume of packed normal sheep 
RBC by adding 1 ml normal rabbit serum to 1 ml packed 
RBC suspended in 4 ml 0.85% NaCl. Allow to stand for 
30 minutes at room temperature. 
c. Centrifuge this suspension at 600 x g for 10 min. 
d. Further dilute this 1;5 concentration of rabbit serum 
by mixing 1 ml with 19 ml of 0.85% NaCl, to give a 1% 
solution. 
Passive hemagglutination test. 
The complete test is presented in Protocol I. 
Protocol 1 
Negative 
Passive Hemagglutination Test Using Endotoxin - Sensitized Cells Controls 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 1:1280 1:2560 1:5120 
1 2 3 4 5 6 7  8  9  1 0  1 1  1 2  
Diluent 
1% Rabbit 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 " 
Serum 
Anti- Serial Two-fold Dilutions 
serum 0.025 0.025 
Coated 
Cells 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 0.025 -
Control 
Ce 1 Is — — — — — — — — — — ~ 0.025 
